These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. Kothary N; Weintraub JL; Susman J; Rundback JH J Vasc Interv Radiol; 2007 Dec; 18(12):1517-26; quiz 1527. PubMed ID: 18057286 [TBL] [Abstract][Full Text] [Related]
8. Preoperative combined with postoperative chemoembolization can improve survival in patients with hepatocellular carcinoma: a single-center study. Liu Y; Yang R J Vasc Interv Radiol; 2009 Apr; 20(4):472-83. PubMed ID: 19250841 [TBL] [Abstract][Full Text] [Related]
9. Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome. Huo TI; Wu JC; Huang YH; Chiang JH; Lee PC; Chang FY; Lee SD Aliment Pharmacol Ther; 2004 May; 19(9):999-1007. PubMed ID: 15113367 [TBL] [Abstract][Full Text] [Related]
10. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Maddala YK; Stadheim L; Andrews JC; Burgart LJ; Rosen CB; Kremers WK; Gores G Liver Transpl; 2004 Mar; 10(3):449-55. PubMed ID: 15004776 [TBL] [Abstract][Full Text] [Related]
11. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort. Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis. Kim HC; Chung JW; Choi SH; Yoon JH; Lee HS; Jae HJ; Lee W; Park JH J Vasc Interv Radiol; 2007 May; 18(5):611-9; quiz 620. PubMed ID: 17494842 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience. Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872 [TBL] [Abstract][Full Text] [Related]
14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
15. Chemoembolization for the treatment of large hepatocellular carcinoma. Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Sugimori N; Igarashi S; Nakashima Y; Notsumata K; Toya D; Tanaka N; Mitsui T; Matsui O J Vasc Interv Radiol; 2010 Aug; 21(8):1226-34. PubMed ID: 20598571 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255 [TBL] [Abstract][Full Text] [Related]
17. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma. Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247 [TBL] [Abstract][Full Text] [Related]
18. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction. Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547 [TBL] [Abstract][Full Text] [Related]
19. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma? Shim JH; Park JW; Choi JI; Kim HB; Lee WJ; Kim CM J Vasc Interv Radiol; 2009 Feb; 20(2):209-16. PubMed ID: 19084432 [TBL] [Abstract][Full Text] [Related]
20. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Hsu CY; Huang YH; Chiou YY; Su CW; Lin HC; Lee RC; Chiang JH; Huo TI; Lee FY; Lee SD Liver Transpl; 2011 May; 17(5):556-66. PubMed ID: 21506244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]